ResearchHematology-Oncology Fellows' Use of Artificial Intelligence: A Multicenter Educational Practice and Needs Assessment Survey
ResearchDaratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.
ResearchAuthor Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.
ResearchA plain language summary of the CEPHEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for people with newly diagnosed multiple myeloma who are not expected to receive a stem cell transplant.
ResearchMultiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.
ResearchOvercoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion.
ResearchOutcomes of Patients With Hematologic Malignancies Who Received Inpatient Palliative Care Consultation.
ResearchInflammation and infection in plasma cell disorders: how pathogens shape the fate of patients.